| Companies sponsors |
AstraZeneca |
| Others |
Department of Health and Social Care |
| |
NHS England |
| Patient carer groups |
Lymphoma Action |
| Professional groups |
Association of Cancer Physicians |
| |
Cancer Research UK |
| |
Royal College of Pathologists |
| |
Royal College of Physicians |
| |
Royal College of Radiologists |
| Associated public health groups |
None |
| Comparator companies |
Accord-UK Ltd (bendamustine) – confidentiality agreement not signed, not participating |
| |
Aspire Pharma (bortezomib) – confidentiality agreement not signed, not participating |
| |
Aurobindo Pharma (bortezomib) – confidentiality agreement not signed, not participating |
| |
Baxter Healthcare Ltd (cyclophosphamide, doxorubicin) – confidentiality agreement not signed, not participating |
| |
Biotech Pharma (bortezomib) – confidentiality agreement not signed, not participating |
| |
Celltrion Healthcare UK Ltd (rituximab) – confidentiality agreement not signed, not participating |
| |
Dr Reddy’s Laboratories UK Ltd (bendamustine, bortezomib) – confidentiality agreement not signed, not participating |
| |
Hospira UK Ltd (cytarabine, vincristine) – confidentiality agreement not signed, not participating |
| |
Jazz Pharmaceuticals UK (cytarabine) – confidentiality agreement not signed, not participating |
| |
Johnson & Johnson Ltd (bortezomib) – confidentiality agreement not signed, not participating |
| |
medac GmbH (bortezomib, doxorubicin) – confidentiality agreement not signed, not participating |
| |
MSN Laboratories Europe (bortezomib) – confidentiality agreement not signed, not participating |
| |
Mylan (bortezomib) – confidentiality agreement not signed, not participating |
| |
Pfizer Ltd (bortezomib, doxorubicin, rituximab) – confidentiality agreement not signed, not participating |
| |
Roche Products Ltd (rituximab) – confidentiality agreement not signed, not participating |
| |
Sandoz Ltd (bortezomib, cyclophosphamide, rituximab) – confidentiality agreement not signed, not participating |
| |
Seacross Pharmaceuticals Ltd (bendamustine, doxorubicin) – confidentiality agreement not signed, not participating |
| |
Sun Pharma (bortezomib) – confidentiality agreement not signed, not participating |
| |
Thornton & Ross Ltd (bortezomib) – confidentiality agreement not signed, not participating |
| |
Tillomed Laboratories Ltd (bortezomib) – confidentiality agreement not signed, not participating |
| |
Zentiva Pharma Ltd (bendamustine) – confidentiality agreement not signed, not participating |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
British National Formulary |
| |
Department of Health - Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
NHS Wales Joint Commissioning Committee |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| Relevant research groups |
Institute of Cancer Research |